Immunity for Health Security Symposium
Current Agenda
9:00-9:30am: Welcome and Opening Remarks
Lord Ara Darzi, Imperial College, London; Flagship Pioneering
Robert Langer, David H. Koch Institute, MIT
9:30-9:55am: Session 1
Immune Policy and Regulatory Standards
Jeffrey M. Drazen, former Editor New England Journal of Medicine*
Panel Discussion – Commissioning Standards and Strategies
Lowell M. Zeta, Partner, Hogan Lovells
Hutan Ashrafian, Chief Scientific Officer, Preemptive Medicine and Health Security Initiative, Flagship Pioneering
9:55-11:15am: Session 2
Immune Correlates of Protection and Immunity Unknowns for SARS-CoV-2
Miles Davenport, The Kirby Institute, University of New South Wales, Sydney, Australia
Population Testing Technologies and Pathways to Meaningful Result Interpretation
Jay Wohlgemuth, CMO, Quest Diagnostics*
Nigel Clarke, VP R&D and CLO, Quest Diagnostics*
Panel Discussion - Performance, interpretation, and choice considerations for serological test platforms
Laura Gillim, Discipline Director, Infectious Disease Immunology, Labcorp
11:15-11:20am: Break
11:20-12:00pm: Session 3
Innovations and Diagnostic Strategies for coming phases of SARS-CoV-2
Panel Discussion & Vote:
Should Antibody testing be utilized in the management and surveillance of COVID?
Lord Ara Darzi, Imperial College, London; Flagship Pioneering*
Michael Osterholm, Center for Infectious Disease Research, University of Minnesota
Eric Topol, Scripps Research Translational Institute
Closing Remarks & Vote Outcome
Lord Ara Darzi, Imperial College, London; Flagship Pioneering
*Moderator